Association between low expression levels of interleukin-9 and colon cancer progression

Experimental and Therapeutic Medicine

Volumn 10, Issue 3, 2015, Pages 942-946

  Huang, Yonghong ^a   Cao, Yunfei ^b   Zhang, Sen ^b   Gao, Feng ^b  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Colon cancer; Interleukin 9; Tumor node metastasis stage

Indexed keywords

INTERLEUKIN 9;

ARTICLE; BLOOD ANALYSIS; CANCER GROWTH; CANCER STAGING; COLON CANCER; CONTROLLED STUDY; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH;

EID: 84937680554     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2015.2588     Document Type: Article

References (36)

1. Jemal A, Bray F, Center MM, et al: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Siegel R, Desantis C and Jemal A: Colorectal cancer statistics, 2014. CA Cancer J Clin 64: 104-117, 2014.
3. Bindea G, Mlecnik B, Angell HK and Galon J: The immune landscape of human tumors: Implications for cancer immunotherapy. OncoImmunology 3: e27456, 2014.
4. Goswami R and Kaplan MH: A brief history of IL-9. J Immunol 186: 3283-3288, 2011.
5. Noelle RJ and Nowak EC: Cellular sources and immune functions of interleukin-9. Nat Rev Immunol 10: 683-687, 2010.
6. Demoulin JB and Renauld JC: Interleukin 9 and its receptor: an overview of structure and function. Int Rev Immunol 16: 345-364, 1998.
7. Kearley J, Erjefalt JS, Andersson C, et al: IL-9 governs allergen-induced mast cell numbers in the lung and chronic remodeling of the airways. Am J Respir Crit Care Med 183: 865-875, 2011.
8. Steenwinckel V, Louahed J, Orabona C, et al: IL-13 mediates in vivo IL-9 activities on lung epithelial cells but not on hematopoietic cells. J Immunol 178: 3244-3251, 2007.
9. Oh CK, Raible D, Geba GP and Molfino NA: Biology of the interleukin-9 pathway and its therapeutic potential for the treatment of asthma. Inflamm Allergy Drug Targets 10: 180-186, 2011.
10. Kim MS, Cho KA, Cho YJ and Woo SY: Effects of interleukin-9 blockade on chronic airway inflammation in murine asthma models. Allergy Asthma Immunol Res 5: 197-206, 2013.
11. Angkasekwinai P, Srimanote P, Wang YH, et al: Interleukin-25 (IL-25) promotes efficient protective immunity against Trichinella spiralis infection by enhancing the antigen-specific IL-9 response. Infect Immun 81: 3731-3741, 2013.
12. Khan WI, Richard M, Akiho H, et al: Modulation of intestinal muscle contraction by interleukin-9 (IL-9) or IL-9 neutralization: Correlation with worm expulsion in murine nematode infections. Infect Immun 71: 2430-2438, 2003.
13. Li H and Rostami A: IL-9: Basic biology, signaling pathways in CD4+ T cells and implications for autoimmunity. J Neuroimmune Pharmacol 5: 198-209, 2010.
14. Yang Y, Du L, Sun M, Kijlstra A and Yang P: IFN-beta inhibits the increased expression of IL-9 during experimental autoimmune uveoretinitis. PLoS One 7: e48566, 2012.
15. Leng RX, Pan HF, Ye DQ and Xu Y: Potential roles of IL-9 in the pathogenesis of systemic lupus erythematosus. Am J Clin Exp Immunol 1: 28-32, 2012.
16. Li H, Nourbakhsh B, Ciric B, Zhang GX and Rostami A: Neutralization of IL-9 ameliorates experimental autoimmune encephalomyelitis by decreasing the effector T cell population. J Immunol 185: 4095-4100, 2010.
17. Purwar R, Schlapbach C, Xiao S, et al: Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells. Nat Med 18: 1248-1253, 2012.
18. Smith SE, Hoelzinger DB, Dominguez AL, Van Snick J and Lustgarten J: Signals through 4-1BB inhibit T regulatory cells by blocking IL-9 production enhancing antitumor responses. Cancer Immunol Immunother 60: 1775-1787, 2011.
19. Sun GG, Wang YD, Cui DW, Cheng YJ and Hu WN: Epithelial membrane protein 1 negatively regulates cell growth and metastasis in colorectal carcinoma. World J Gastroenterol 20: 4001-4010, 2014.
20. Cerkovnik P, Perhavec A, Zgajnar J and Novakovic S: Optimization of an RNA isolation procedure from plasma samples. Int J Mol Med 20: 293-300, 2007.
21. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408, 2001.
22. Ouyang H, Shi Y, Liu Z, Feng S, et al: Increased interleukin-9 and CD4 +IL-9+ T cells in patients with systemic lupus erythematosus. Mol Med Rep 7:1031-1037, 2013.
23. de Vries VC, Wasiuk A, Bennett KA, et al: Mast cell degranulation breaks peripheral tolerance. Am J Transplant 9: 2270-2280, 2009.
24. Fábrega E, López-Hoyos M, San Segundo D, et al: Interleukin-9 in stable liver transplant recipients. Transplant Proc 44: 1536-1538, 2012.
25. Zhang J, Wang WD, Geng QR, et al: Serum levels of interleukin-9 correlate with negative prognostic factors in extranodal NK/T-cell lymphoma. PLoS One 9: e94637, 2014.
26. Lv X, Feng L, Fang X, Jiang Y and Wang X: Overexpression of IL-9 receptor in diffuse large B-cell lymphoma. Int J Clin Exp Pathol 6: 911-916, 2013.
27. Hamre H, Zeller B, Kanellopoulos A, et al: Serum cytokines and chronic fatigue in adults surviving after childhood leukemia and lymphoma. Brain Behav Immun 30: 80-87, 2013.
28. Kobayashi H, Kumai T, Hayashi S, et al: A naturally processed HLA-DR-bound peptide from the IL-9 receptor alpha of HTLV-1-transformed T cells serves as a T helper epitope. Cancer Immunol Immunother 61: 2215-2225, 2012.
29. Fischer M, Bijman M, Molin D, et al: Increased serum levels of interleukin-9 correlate to negative prognostic factors in Hodgkin's lymphoma. Leukemia 17: 2513-2516, 2003.
30. Hornakova T, Staerk J, Royer Y, et al: Acute lymphoblastic leukemia-associated JAK1 mutants activate the Janus kinase/STAT pathway via interleukin-9 receptor alpha homodimers. J Biol Chem 284: 6773-6781, 2009.
31. Qiu L, Lai R, Lin Q, et alAutocrine release of interleukin-9 promotes Jak3-dependent survival of ALK+ anaplastic large-cell lymphoma cells. Blood 108: 2407-2415, 2006.
32. Knoops L and Renauld JC: IL-9 and its receptor: from signal transduction to tumorigenesis. Growth Factors 22: 207-215, 2004.
33. Bauer JH, Liu KD, You Y, Lai SY and Goldsmith MA: Heteromerization of the gammac chain with the interleukin-9 receptor alpha subunit leads to STAT activation and prevention of apoptosis. J Biol Chem 273: 9255-9260, 1998.
34. Ye ZJ, Zhou Q, Yin W, Yuan ML, et alDifferentiation and immune regulation of IL-9-producing CD4+ T cells in malignant pleural effusion. Am J Respir Crit Care Med 186: 1168-1179, 2012.
35. Lu Y, Hong S, Li H, et al: Th9 cells promote antitumor immune responses in vivo. J Clin Invest 122: 4160-4171, 2012.
36. Tran E, Nielsen JS, Wick DA, et al: Polyfunctional T-cell responses are disrupted by the ovarian cancer ascites environment and only partially restored by clinically relevant cytokines. PLoS One 5: e15625, 2010.